These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1669353)

  • 21. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulatory effect of natural killer cells: do "NK-reg cells" exist?
    Zhang C; Zhang J; Tian Z
    Cell Mol Immunol; 2006 Aug; 3(4):241-54. PubMed ID: 16978532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle versus brain: chronic fatigue syndrome.
    Lloyd AR
    Med J Aust; 1990 Nov; 153(9):530-4. PubMed ID: 2233475
    [No Abstract]   [Full Text] [Related]  

  • 24. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.
    Maes M; Mihaylova I; De Ruyter M
    J Affect Disord; 2006 Feb; 90(2-3):141-7. PubMed ID: 16338007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.
    Burstein Y; Zakuth V; Rechavi G; Spirer Z
    J Clin Lab Immunol; 1987 Jul; 23(3):149-51. PubMed ID: 2959782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T gamma and T mu lymphocytes. Clinical and experimental studies of human T gamma and T mu lymphocytes participating in the immune response.
    Jensen JR
    Dan Med Bull; 1984 Apr; 31(2):73-89. PubMed ID: 6233103
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis].
    Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of laboratory findings for patients with chronic fatigue syndrome.
    Buchwald D; Komaroff AL
    Rev Infect Dis; 1991; 13 Suppl 1():S12-8. PubMed ID: 1902321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells and natural killer cell activity in chronic fatigue syndrome.
    Whiteside TL; Friberg D
    Am J Med; 1998 Sep; 105(3A):27S-34S. PubMed ID: 9790479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sources of confounding in immunologic data.
    Herberman RB
    Rev Infect Dis; 1991; 13 Suppl 1():S84-6. PubMed ID: 2020807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic fatigue syndrome--false avenues and dead ends.
    Lancet; 1991 Feb; 337(8737):331-2. PubMed ID: 1671237
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological aspects of pathophysiology of chronic fatigue syndrome].
    Matsumoto Y
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Jun; 22(3):111-22. PubMed ID: 11126662
    [No Abstract]   [Full Text] [Related]  

  • 34. Cortisol deficiency may account for elevated apoptotic cell population in patients with chronic fatigue syndrome.
    Baschetti R
    J Intern Med; 1999 Apr; 245(4):409-10. PubMed ID: 10356605
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological abnormalities in the chronic fatigue syndrome.
    Med J Aust; 1990 Jan; 152(1):50-2. PubMed ID: 2294379
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronic fatigue syndrome].
    Kitani T
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1571-6. PubMed ID: 8245661
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating lymphokine levels in the chronic fatigue syndrome.
    Straus SE; Dale JK; Peter JB; Dinarello CA
    J Infect Dis; 1989 Dec; 160(6):1085-6. PubMed ID: 2584758
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-neuronal antibody levels in chronic fatigue syndrome patients with neurologic abnormalities.
    Buchwald D; Wener MH; Komaroff AL
    Arthritis Rheum; 1991 Nov; 34(11):1485-6. PubMed ID: 1953828
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter to the editor.
    Van Houdenhove B
    Semin Arthritis Rheum; 2003 Oct; 33(2):134-5. PubMed ID: 14625821
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic fatigue study shows syndrome's complexity.
    Couzin-Frankel J
    Science; 2024 Feb; 383(6685):804-805. PubMed ID: 38386732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.